Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-23

FDA Approved: PHENTERMINE AND TOPIRAMATE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for phentermine and topiramate from Prasco Laboratories, updating the label for obesity weight-management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phentermine and topiramate (Phentermine and topiramate)

Snippet

SUPPL AP for PHENTERMINE AND TOPIRAMATE (PHENTERMINE AND TOPIRAMATE)